Team: Global Market Access and Pricing – Diabetes& Access, Product & Portfolio Strategy
Location: Bangalore, Novo Nordisk Global Business Services (GBS), India
Shape how millions of people gain access to the next generation of diabetes therapies. In this role, you will own asset-level market access and payer value strategy at a defining moment for Novo Nordisk – translating science into reimbursement reality across the globe.
Your new role
As Senior Global Market Access Lead, you will own and drive market access and payer value strategy across pipeline, launch, and lifecycle stages for the assigned asset(s) within the diabetes and cardio portfolio. Operating with high independence, you will integrate payer insight, HTA strategy, and value communication into the heart of asset development – influencing how our therapies reach patients in 194 countries.
Day-to-day, your responsibilities will include:
Your new department
In Product & Portfolio Strategy we drive commercial strategy, medical affairs and business development across all therapy areas. We act as a connector and compass, guiding the new Novo Nordisk portfolio for sustained competitiveness upstream, and maximising portfolio potential through successful commercial strategies and competitive launches downstream.
You will join Global Market Access and Pricing – Diabetes & Access, the team responsible for de-fining, shaping, and operationalising payer-relevant value and access strategies across the asset lifecycle. We work at the intersection of science, evidence, and health systems – partnering close-ly with HEOR, Pricing, Payer Evidence, Clinical Development, Medical, Commercial, and region-al/affiliate teams to ensure payer insights and access strategy are embedded into pipeline development, launch preparation, and lifecycle management.
Your skills & qualifications
We are looking for a strategic, payer-savvy market access professional who thrives in high-ambiguity environments and enjoys turning complex evidence into clear access outcomes. You'll bring with you:
Working at Novo Nordisk
Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with determination, constant curiosity and a commitment to finding better ways forward. For over 100 years, this dedication has driven us to build a company focused on lasting change for long-term health. One where diverse thinking, shared purpose and mutual respect come together to create extraordinary results. When you join us, you're not just starting a job – you're becoming part of a story that spans generations.
What we offer
There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.
Deadline
6 July 2026. Applications are reviewed on an ongoing basis, so please apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and preventing diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health.
Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html